Macrophage polarization toward M1 phenotype through NF-κB signaling in patients with Behçet's disease

Background Macrophages are key innate immune cells implicated in the pathogenesis of Behçet's disease (BD), and macrophage polarization plays a pivotal role in inflammatory response. This study aimed to investigate the role of BD serum on the phenotypes and functions of macrophage polarization....

Full description

Saved in:
Bibliographic Details
Published inArthritis research & therapy Vol. 24; no. 1
Main Authors Wu, Xiuhua, Wang, Zhimian, Shi, Jing, Yu, Xin, Li, Chaoran, Liu, Jinjing, Zhang, Fengchun, Chen, Hua, Zheng, Wenjie
Format Journal Article
LanguageEnglish
Published BioMed Central Ltd 04.11.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Macrophages are key innate immune cells implicated in the pathogenesis of Behçet's disease (BD), and macrophage polarization plays a pivotal role in inflammatory response. This study aimed to investigate the role of BD serum on the phenotypes and functions of macrophage polarization. Methods BD or HC serum-treated human monocyte-derived macrophages (HMDMs) were examined M1/M2 phenotypes using flow cytometry and ELISA. The phagocytic capacity of HMDMs and CD4.sup.+T cell differentiation facilitated by HMDMs were measured by flow cytometry. Transcriptome analysis of BD and HC serum-stimulated HMDMs was conducted to identify differentially expressed genes. NF-κB signaling was examined using western blot to explore the mechanism of macrophage polarization induced by BD serum. Results BD serum-treated macrophages expressed a higher level of CD86, IL-12, and TNF-[alpha] and a lower level of CD163, which were compatible with the M1-like phenotype. Furthermore, BD serum-treated macrophages showed enhanced phagocytic capacity and promoted more Th1 cell differentiation. Sixty-one differentially expressed genes were identified between BD and HC serum-treated macrophages and were enriched in NF-κB signaling. BD serum-treated macrophages showed upregulated p-p65 and downregulated IκB[alpha], and NF-κB inhibitor attenuated BD serum-stimulated M1-like phenotype. Conclusions BD serum promoted macrophage polarization toward a proinflammatory M1-like phenotype through NF-κB signaling and potentially facilitated inflammation in BD. M1 polarized macrophages may be a potential therapeutic target for BD. Keywords: Behçet's disease, Macrophage polarization, Phagocytosis, Th1 differentiation, NF-κB pathway
AbstractList Macrophages are key innate immune cells implicated in the pathogenesis of Behçet's disease (BD), and macrophage polarization plays a pivotal role in inflammatory response. This study aimed to investigate the role of BD serum on the phenotypes and functions of macrophage polarization. BD or HC serum-treated human monocyte-derived macrophages (HMDMs) were examined M1/M2 phenotypes using flow cytometry and ELISA. The phagocytic capacity of HMDMs and CD4.sup.+T cell differentiation facilitated by HMDMs were measured by flow cytometry. Transcriptome analysis of BD and HC serum-stimulated HMDMs was conducted to identify differentially expressed genes. NF-κB signaling was examined using western blot to explore the mechanism of macrophage polarization induced by BD serum. BD serum-treated macrophages expressed a higher level of CD86, IL-12, and TNF-[alpha] and a lower level of CD163, which were compatible with the M1-like phenotype. Furthermore, BD serum-treated macrophages showed enhanced phagocytic capacity and promoted more Th1 cell differentiation. Sixty-one differentially expressed genes were identified between BD and HC serum-treated macrophages and were enriched in NF-κB signaling. BD serum-treated macrophages showed upregulated p-p65 and downregulated IκB[alpha], and NF-κB inhibitor attenuated BD serum-stimulated M1-like phenotype. BD serum promoted macrophage polarization toward a proinflammatory M1-like phenotype through NF-κB signaling and potentially facilitated inflammation in BD. M1 polarized macrophages may be a potential therapeutic target for BD.
Background Macrophages are key innate immune cells implicated in the pathogenesis of Behçet's disease (BD), and macrophage polarization plays a pivotal role in inflammatory response. This study aimed to investigate the role of BD serum on the phenotypes and functions of macrophage polarization. Methods BD or HC serum-treated human monocyte-derived macrophages (HMDMs) were examined M1/M2 phenotypes using flow cytometry and ELISA. The phagocytic capacity of HMDMs and CD4.sup.+T cell differentiation facilitated by HMDMs were measured by flow cytometry. Transcriptome analysis of BD and HC serum-stimulated HMDMs was conducted to identify differentially expressed genes. NF-κB signaling was examined using western blot to explore the mechanism of macrophage polarization induced by BD serum. Results BD serum-treated macrophages expressed a higher level of CD86, IL-12, and TNF-[alpha] and a lower level of CD163, which were compatible with the M1-like phenotype. Furthermore, BD serum-treated macrophages showed enhanced phagocytic capacity and promoted more Th1 cell differentiation. Sixty-one differentially expressed genes were identified between BD and HC serum-treated macrophages and were enriched in NF-κB signaling. BD serum-treated macrophages showed upregulated p-p65 and downregulated IκB[alpha], and NF-κB inhibitor attenuated BD serum-stimulated M1-like phenotype. Conclusions BD serum promoted macrophage polarization toward a proinflammatory M1-like phenotype through NF-κB signaling and potentially facilitated inflammation in BD. M1 polarized macrophages may be a potential therapeutic target for BD. Keywords: Behçet's disease, Macrophage polarization, Phagocytosis, Th1 differentiation, NF-κB pathway
Audience Academic
Author Yu, Xin
Wu, Xiuhua
Shi, Jing
Liu, Jinjing
Wang, Zhimian
Zhang, Fengchun
Li, Chaoran
Zheng, Wenjie
Chen, Hua
Author_xml – sequence: 1
  fullname: Wu, Xiuhua
– sequence: 2
  fullname: Wang, Zhimian
– sequence: 3
  fullname: Shi, Jing
– sequence: 4
  fullname: Yu, Xin
– sequence: 5
  fullname: Li, Chaoran
– sequence: 6
  fullname: Liu, Jinjing
– sequence: 7
  fullname: Zhang, Fengchun
– sequence: 8
  fullname: Chen, Hua
– sequence: 9
  fullname: Zheng, Wenjie
BookMark eNptkLFOwzAURT0UibbwA0yWGJhSbMeJnbGtKCC1sHSvjP2SGKV2FBsh-hH8Bv_ASH8MSzAwoKenJ917zxvuBI2cd4DQBSUzSmV5HWhORJERxtJWucwOIzSmXMiszAt-iiYhPJPkVoyPkd0oPfi-VQ3g3ndqsAcVrXc4-lc1GLyhuG_B-fjWA47t4F-aFj-ssuP71-cCB9s41VnXYOtwn0BwMeBXG1u8gPb4AfEqYGMDqABn6KRWXYDz3ztF29XNdnmXrR9v75fzddaUgmSCc0WFJIYwBXkhCTWUKaINB8NqDlA-aU6I0JVmgteSVlzUhRG5BJZUmk_R5c_bRnWws672cVB6b4PezUVOOC1lSVJq9k8qjYG91anP2ib9D_AN2P5rYA
ContentType Journal Article
Copyright COPYRIGHT 2022 BioMed Central Ltd.
Copyright_xml – notice: COPYRIGHT 2022 BioMed Central Ltd.
DOI 10.1186/s13075-022-02938-z
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID A730416860
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
.GJ
0R~
23N
2WC
4.4
5GY
5VS
6J9
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
ABUWG
ACGFS
ACJQM
ADBBV
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIAM
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
E3Z
EBD
EBLON
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
HZ~
INH
INR
ITC
KQ8
M1P
O5R
O5S
O9-
PGMZT
PHGZM
PHGZT
PIMPY
PMFND
PQQKQ
PROAC
PSQYO
RBZ
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
U2A
UKHRP
WOQ
ID FETCH-LOGICAL-g670-744a1780d02ae35801d12a0cd4ed2f4ee6bc4007c9c274f81947f5d738e207c13
ISSN 1478-6354
IngestDate Tue Jun 17 21:06:34 EDT 2025
Tue Jun 10 20:49:44 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-g670-744a1780d02ae35801d12a0cd4ed2f4ee6bc4007c9c274f81947f5d738e207c13
ParticipantIDs gale_infotracmisc_A730416860
gale_infotracacademiconefile_A730416860
PublicationCentury 2000
PublicationDate 20221104
PublicationDateYYYYMMDD 2022-11-04
PublicationDate_xml – month: 11
  year: 2022
  text: 20221104
  day: 04
PublicationDecade 2020
PublicationTitle Arthritis research & therapy
PublicationYear 2022
Publisher BioMed Central Ltd
Publisher_xml – name: BioMed Central Ltd
SSID ssj0022924
Score 2.3803735
Snippet Background Macrophages are key innate immune cells implicated in the pathogenesis of Behçet's disease (BD), and macrophage polarization plays a pivotal role in...
Macrophages are key innate immune cells implicated in the pathogenesis of Behçet's disease (BD), and macrophage polarization plays a pivotal role in...
SourceID gale
SourceType Aggregation Database
SubjectTerms Analysis
Behcet's disease
Care and treatment
Diagnosis
Health aspects
Macrophages
Phenotype
T cells
Title Macrophage polarization toward M1 phenotype through NF-κB signaling in patients with Behçet's disease
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1PT9swFLcYSGgXtA2msTHkwxCHKBC7TpwcWwRCSOFC0apdkOM4SyUWpjW98CH4GvsOO44vtvcc50_FDmyHRpXbuFV_v77_75mQT1LDv3nEMfSWJb5QWvoJ6F0_yjPGCwVK186ZTS-j82txMQtnfa2q7S6psyN9_9e-kv9BFdYAV-yS_Qdku01hAZ4DvnAFhOH6LIxThQdwlVh28x1dVNdTCfYk1sJ6KfOwguvOhlnbA3kuz3xMjsenByf8YDKeeFjBoW5da4sbs-p63iamtIl0iRkLuVjJ5nSTa2FjnIvkubFBpSVTvTqs4PMSoZzNl-WyVwMuUv2lnH8bcPTKnjLsXbQq1R4a1txdDUMU4N1i2LUPUa6GqwflSihwBXixYPSIoURuuqqHzHsq6G3eaQEaWGKHOYdHAqL7vldrXbHhGIQYmJ1xFLwgGxy8CRSH13zc-eU8ac4-br9K21sVR8dPP8Cp7oERMn1Ftpz3QMcNFV6TNVO9IZupq4_YJvOeEXTICNowgqaMdoygjhEUGPH48PvXhHZMoPOKtkygyAQKTHj8aerDBXUc2CHTs9PpybnvDtPwv0Yy8KUQisk4yAOuDKa-Wc64CnQuTM4LYUyUaRDnUieaS1GAnShkEeZyFBsOq2z0lqxXd5V5R6gsWFaEYZglYM7GSaDAomSxYQXX4B_oZJcc4i90g3gB4Fq5Rg-4G2eN3fR47JK9lXeCZNODl98_e6MP5GXPuz2yXv9Ymo9gLNbZvg2y7FvA_wBMfWqH
linkProvider Springer Nature
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Macrophage+polarization+toward+M1+phenotype+through+NF-%C3%8E%C2%BAB+signaling+in+patients+with+Beh%C3%A7et%27s+disease&rft.jtitle=Arthritis+research+%26+therapy&rft.au=Wu%2C+Xiuhua&rft.au=Wang%2C+Zhimian&rft.au=Shi%2C+Jing&rft.au=Yu%2C+Xin&rft.date=2022-11-04&rft.pub=BioMed+Central+Ltd&rft.issn=1478-6354&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs13075-022-02938-z&rft.externalDocID=A730416860
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6354&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6354&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6354&client=summon